| Filed On | Filing |
|---|---|
| 16 Mar 2020 |
Form 4/A: Matsuda Kazuko, Director
Bought 2,000 shares ($7.24K) |
| 19 Jan 2016 |
Form 4/A: Okajima Masatsune, VP and Head of Japanese Office
Granted 135,000 Employee Stock Option (Right to Buy) |
| 19 Jan 2016 |
Form 4/A: OBrien Geoffrey, Vice President
Granted 135,000 Employee Stock Option (Right to Buy) |
| 19 Jan 2016 |
Form 4/A: Matsuda Kazuko, Chief Medical Officer
Granted 225,000 Employee Stock Option (Right to Buy) |
| 19 Jan 2016 |
Form 4/A: Iwaki Yuichi, Director
Granted 370,000 Employee Stock Option (Right to Buy) |
| 06 Apr 2011 |
Form 4/A: Johnson Kirk William, Chief Scientific Officer
Bought 1,700 shares · Acquired 1,700 Common Stock Warrants (Right to Buy) (Open Market Purchase) |
| 20 Sep 2006 |
Form 4/A: Okajima Masatsune, VP and Head of Japanese Office
Granted 400,000 Stock Option (right to buy) |
| 18 May 2006 |
Form 4/A: Iwaki Yuichi, Director
Granted 10,000 Stock Option (right to buy) |
Loading...